Veru Inc. (VERU)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	55	113	65	923	681	183
Market Cap Growth	-29.99%	73.42%	-92.97%	35.55%	272.13%	30.30%
Enterprise Value	38	97	64	843	571	181
Last Close Price	0.37	0.77	0.72	11.52	8.53	2.62
PE Ratio	-	-	-	-	92.12	-
PS Ratio	3.23	6.67	3.98	23.46	11.12	4.30
PB Ratio	2.60	3.48	3.30	11.15	4.47	6.08
P/TBV Ratio	3.86	4.43	5.07	12.83	4.82	10.47
PEG Ratio	-	1.32	1.32	1.32	1.32	1.32
EV/Sales Ratio	2.28	5.75	3.95	21.41	9.32	4.26
Debt / Equity Ratio	0.16	0.43	0.74	0.19	0.09	0.47
Asset Turnover	0.32	0.31	0.18	0.25	0.53	0.81
Inventory Turnover	-	2.04	1.14	1.24	2.17	2.28
Quick Ratio	3.49	2.43	0.79	2.16	8.32	1.28
Current Ratio	3.80	2.97	1.29	2.69	9.63	1.83
Return on Equity (ROE)	-93.86%	-145.40%	-181.81%	-71.50%	8.11%	-60.77%
Return on Assets (ROA)	-49.03%	-43.16%	-64.47%	-33.29%	-2.96%	-1.41%
Return on Capital (ROIC)	-61.22%	-59.32%	-89.95%	-39.42%	-3.23%	-1.67%
Earnings Yield	-66.46%	-33.58%	-143.51%	-9.10%	1.09%	-10.37%
FCF Yield	-53.39%	-19.40%	-136.62%	-5.22%	-2.34%	-1.11%
Buyback Yield / Dilution	-37.70%	-58.73%	-6.05%	4.39%	-25.54%	-5.42%
Total Shareholder Return	-37.70%	-58.73%	-6.05%	4.39%	-25.54%	-5.42%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q